A Study of NGM621 in Participants With Geographic Atrophy

Clinical trial NCT04465955 · COMPLETED

Trial details

NCT number: NCT04465955
Sponsor: NGM Biopharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Geographic Atrophy

Start date: 2020-07-22
Primary completion: 2022-08-16
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.